Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently without UK marketing authorisation from the MHRA or EMA
After creating an individualized treatment plan including dietary and lifestyle changes in addition to the medication, we will see you monthly
Cysteine/glutathione deficiency: a significant and treatable corollary of disease, in The Therapeutic Use of N-Acetylcysteine (NAC) in Medicine
As mentioned, clinical trial evidence suggests Zepbound may lead to a greater percentage of weight loss compared to Wegovy, potentially due to its dual-hormone action
